Greenwich Lifesciences Inc · Stock-Based Compensation

Latest reported$1.48Mperiod endingJun 30, 2026

GLSI Quarterly Stock-Based Comp ($0.00 → $1.48M)

Quarterly stock-based compensation

High-resolution chart · PNG

GLSI stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Greenwich Lifesciences Inc Stock-Based Compensation — Quarterly (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	1,484,762
Mar 31, 2026	1,544,214
Dec 31, 2025	0
Sep 30, 2025	1,544,214
Jun 30, 2025	1,544,214
Mar 31, 2025	1,544,214
Dec 31, 2024	5,469,761
Sep 30, 2024	594,522
Jun 30, 2024	594,522
Mar 31, 2024	594,522
Dec 31, 2023	594,522
Sep 30, 2023	594,522
Jun 30, 2023	594,522
Mar 31, 2023	594,522
Dec 31, 2022	594,522
Sep 30, 2022	759,573
Jun 30, 2022	224,503
Mar 31, 2022	165,267
Dec 31, 2021	165,429
Sep 30, 2021	165,051
Jun 30, 2021	165,051
Mar 31, 2021	165,051
Dec 31, 2020	165,051
Sep 30, 2020	165,051
Jun 30, 2020	173,943
Mar 31, 2020	173,943
Dec 31, 2019	194,943
Sep 30, 2019	0
Jun 30, 2019	0
Mar 31, 2019	0